Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
Colorectal Disease2018Vol. 20(5), pp. 371–382
Citations Over TimeTop 10% of 2018 papers
Rebecca Fish, Caroline Sanders, Neil Ryan, Sabine N van der Veer, Andrew G. Renehan, Paula Williamson
Abstract
Outcomes reported in studies evaluating chemoradiotherapy for ASCC were heterogenous and definitions varied widely. Outcomes likely to be important to patients, such as ano-rectal function, toxicity and QoL, have been neglected. A COS for future trials will address these issues.